Tubulis
Christian Grøndahl, Dr. Med, DVM, PhD, MBA, serves as the Chairman of the Board.
Christian founded or co-founded multiple biotechnology companies exploring novel technology platforms including SNIPR Biome, Freeline Therapeutics, Gyroscope Therapeutics, Quadrucept Bio and Folium Food Science. Since 2015, he has held the position of Co-founder and CEO of SNIPR Biome. Prior, he served as the CEO of Kymab as well as the CSO and Head of R&D at Zealand Pharma. He also worked in R&D and held various corporate development roles at Novo Nordisk.
Christian studied Veterinary Medicine and obtained his PhD and MD degrees at the University of Copenhagen, Denmark. In 2007 he received his MBA from the University of Lausanne, Switzerland.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Tubulis
2 followers
Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. They will advance a range of conjugates, unlimited by indication, using their own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.